Immunofluorescence Assay: A Method to Identify Tumor Cells Captured on a Medical Wire
JoVE Encyclopedia of Experiments
Cancer Research
0 views • 4:32 min • April 30th, 2023
Loading...
Overview
This article describes a method for capturing circulating tumor cells (CTCs) using a functionalized wire coated with antibodies. The process involves incubating the wire with tumor cells, followed by immunofluorescent staining to identify the bound CTCs.
Key Study Components
Area of Science
- Cell Biology
- Oncology
- Immunology
Background
- Circulating tumor cells are important for cancer diagnosis and monitoring.
- Functionalized surfaces can enhance the capture of specific cell types.
- Immunofluorescent techniques allow for the visualization of bound cells.
- This method provides a potential tool for studying CTCs in various cancers.
Purpose of Study
- To develop a reliable method for capturing and identifying CTCs.
- To utilize functionalized wires for enhanced specificity in cell capture.
- To demonstrate the effectiveness of immunofluorescent staining in visualizing CTCs.
Methods Used
- Functionalized wire coated with antibodies is prepared.
- Wire is incubated with tumor cells to allow binding.
- Cells are fixed and stained with fluorochrome-conjugated antibodies.
- Fluorescent microscopy is used to visualize the captured CTCs.
Main Results
- Successful binding of CTCs to the functionalized wire was observed.
- Immunofluorescent staining effectively highlighted the CTCs.
- The method demonstrated reproducibility in capturing CTCs.
- Fluorescent microscopy provided clear visualization of the cells.
Conclusions
- This method offers a promising approach for CTC capture and analysis.
- Functionalized wires can be utilized for specific cell targeting.
- Immunofluorescent techniques enhance the detection of CTCs in research.
Frequently Asked Questions
What are circulating tumor cells?
Circulating tumor cells (CTCs) are cancer cells that have detached from a primary tumor and circulate in the bloodstream.
How does the functionalized wire capture CTCs?
The wire is coated with antibodies that specifically bind to antigens on the surface of CTCs, allowing for their capture during incubation.
What is the role of immunofluorescent staining?
Immunofluorescent staining uses fluorochrome-conjugated antibodies to label the captured CTCs, making them visible under a fluorescent microscope.
Why is PBS used in the protocol?
Phosphate buffered saline (PBS) is used to rinse the wire and maintain a stable pH during the incubation and washing steps.
What temperature is required for the overnight incubation?
The wire should be incubated overnight at 4 degrees Celsius in the dark to prevent degradation of the fluorochrome.
How can this method be applied in cancer research?
This method can be used to study the biology of CTCs, monitor treatment responses, and develop personalized cancer therapies.
Executive Industry Relevance
Immunofluorescence assays for circulating tumor cells (CTCs) captured on functionalized medical wires enable direct, in situ identification of rare tumor cells from patient blood. This approach addresses a critical discovery-stage challenge by providing a robust platform for target validation and mechanistic de-risking in oncology pipelines. The method enhances predictive confidence at the interface of early discovery and translational research, supporting risk-adjusted portfolio decisions.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct interrogation of tumor cell surface antigens for functional target validation.
- Supports biological de-risking by isolating and characterizing CTCs from complex biological matrices.
- Facilitates predictive confidence in target engagement and pathway relevance.
Screening & Assay Development
- Prepares validated CTC samples for downstream immunofluorescence-based assays.
- Standardizes detection of rare cell populations with quantitative fluorescence readouts.
- Enables reproducible evaluation of antibody specificity and binding efficiency.
Translational & Preclinical Research
- Aligns CTC capture and identification with disease-relevant biomarker strategies.
- Provides continuity from discovery-stage antigen validation to preclinical model development.
- Supports risk-adjusted advancement of oncology assets based on direct cellular evidence.
Pipeline & Workflow Integration
This immunofluorescence assay integrates into the oncology discovery continuum from early target validation through preclinical research, enabling direct measurement of CTCs as translational biomarkers.
- Discovery Biology: Supports hypothesis testing and pathway clarification by isolating and identifying CTCs based on antigen expression.
- Screening: Delivers assay-ready, reproducible CTC samples for quantitative immunofluorescence analysis.
- Analytics: Provides fluorescence-based measurements to compare antibody binding and cell capture efficiency.
- Translational Research: Bridges discovery and preclinical validation by enabling CTC-based biomarker studies.
- Enterprise Reuse: Establishes a reusable platform for rare cell capture and analysis across oncology programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in target validation.
- Operational Value: Standardizes rare cell detection and supports reproducibility across studies.
- Strategic Value: Informs go/no-go decisions and enhances capital efficiency by providing direct cellular evidence.
- Portfolio Impact: Enables risk-adjusted prioritization of oncology assets based on robust CTC data.
Implementation Considerations
- Requires expertise in immunofluorescence and rare cell handling.
- Needs access to functionalized wires, fluorescence microscopy, and antibody reagents.
- Demands cross-team standardization of staining and imaging protocols.
- May require adaptation for different tumor cell antigens or blood sample types.
- Dependent on antibody specificity and fluorescence signal quality for reliable detection.
Biopharma FAQs
Why does null hypothesis testing matter for CTC immunofluorescence assays?
Null hypothesis testing ensures that observed fluorescence signals from captured CTCs are statistically significant and not due to background or nonspecific binding, supporting robust target validation decisions.
How does independent variable isolation fit the CTC capture workflow?
Isolating variables such as antibody specificity and incubation conditions allows teams to attribute CTC capture and fluorescence outcomes directly to the tested parameters, strengthening discovery-stage conclusions.
What do quantitative fluorescence measurements enable in CTC analysis?
Quantitative fluorescence measurements provide objective data on antibody binding and CTC abundance, enabling comparison across samples and supporting data-driven advancement decisions.
Why are replication requirements critical for cross-functional CTC studies?
Replication ensures that CTC capture and identification results are reproducible across teams and experiments, facilitating reliable cross-functional collaboration and portfolio alignment.
What statistical analysis capabilities are needed before CTC assay implementation?
Robust statistical analysis is required to validate fluorescence thresholds, assess assay sensitivity, and confirm specificity, ensuring the method meets enterprise R&D standards before broader deployment.
11:31
Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer
Related Videos
0 Views
10:49
Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens
Related Videos
0 Views
10:29
Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Related Videos
0 Views
04:05
CTC Immunofluorescence Assay : A Technique to Characterize Circulating Tumor Cells
Related Videos
0 Views
05:29
3D DNA FISH: A Technique to Locate a Specific Gene on a Chromosome
Related Videos
0 Views
04:08
Functionalized Wire-based Target Cell Isolation: An Ex Vivo Technique to Isolate Cancer Cells from Spiked Peripheral Blood
Related Videos
0 Views
04:13
A Technique to Assess the In Vivo Localization of Tumor-Specific Antibodies
Related Videos
0 Views
05:01
Multiplexed Immunofluorescence Imaging to Analyze Immunotherapy-Resistant T Cell Subpopulations
Related Videos
0 Views
07:43
Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
Related Videos
0 Views
09:32
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
Related Videos
0 Views
Last updated: 22 August 2026